Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience

A Time to Kill: Targeting Apoptosis in Cancer

(2015) Jean Koff et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer

(2014) Florent Mouliere et al.   Molecular Oncology

Intergenotypic Variation of Endothelial Dysfunction and Inflammatory Markers in Eclampsia

(2012) Deepika Sharma et al.   HYPERTENSION IN PREGNANCY

SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses

(2012) M. Pazzagli et al.   METHODS

Cell-free Nucleic Acids as Potential Markers for Preeclampsia

(2011) S. Hahn et al.   PLACENTA

High Fragmentation Characterizes Tumour-Derived Circulating DNA

(2011) Florent Mouliere et al.   PLoS One

Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?

(2009) Maniesh van der Vaart et al.   CLINICAL BIOCHEMISTRY